Use of nonopioid analgesics and adjunctive agents in the management of pain in rheumatic diseases.
Antirheumatic analgesic medications generally fall into one of the following categories: acetaminophen, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), tramadol, traditional opioids, or adjunctive analgesics. This article does not discuss corticosteroids, opioids, or topical analgesics. Acetaminophen, usually indicated early for mild pain, is often used in combination with other drugs. It has established safety. Traditional NSAIDs are effective in relieving moderate pain in certain inflammatory and noninflammatory conditions. There are many effective choices, but as a class it is fraught with the risk of serious peptic ulcer disease and its complications. Cyclooxygenase-2 specific inhibitors are NSAIDS that reduce the gastrointestinal risk and platelet-mediated bleeding. All NSAIDs may produce peripheral edema, hypertension, and potentiate warfarin. The evidence that coxibs cause thrombotic heart disease is weak. Tramadol is an alternative to musculoskeletal pain management, particularly in patients with moderate to moderately severe pain who do not respond to or who cannot tolerate acetaminophen, NSAIDs, or opioids. The role of analgesic adjuvants is discussed.
Katz
Warren A
WA
Division of Rheumatology, University of Pennsylvania Health System/Presbyterian Medical Center, Philadelphia, Pennsylvania, USA. wakatzmd@aol.com
D000700:Analgesics / Q000627:therapeutic use*; D006801:Humans; D010166:Palliative Care / Q000379:methods*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000700:Analgesics